We are monitoring the impact of COVID-19 on APAC Bleeding Disorders Treatment Market Get in touch with us for detailed analysis Know More
Share on

Asia Pacific Bleeding Disorders Treatment Market Research Report - Segmented By Drug Class, Type & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2022 to 2027)

Published: January, 2022
ID: 3232
Pages: 146

Asia Pacific Bleeding Disorders Treatment Market Size & Growth (2022 to 2027)

As per the research report, the size of the Asia Pacific Bleeding Disorders Treatment Market is valued at USD 2.62 billion in 2022 and is estimated to be growing at a CAGR of 8.90%, to reach USD 4.02 billion by 2027 during the forecast period 2022 to 2027.

The market is driven by the growing need for bleeding disorders drugs to meet critical medical requirements to limit blood loss and is one of the significant growth drivers in this market. Moreover, the unavailability of a definitive treatment plan of completely removing the disorder permanently from the patient's body is also influencing the market growth. In addition, there is a constant increase in the number of patients diagnosed with bleeding disorders, increased awareness of bleeding disorders, improved quickness, an extensive network of diagnostic and treatment centers, accurate diagnostic tests and proactive government initiatives are some of the essential factors helping in establishing this market.

Key companies are focusing on intensive research and development to provide more effective drugs to patients to reduce side-effects and help in the wide-spread adoption of these technologically advanced products in the APAC healthcare industry. There were around 730 million people over the age of 65 in 2020, and they represented 9.35% of the total world population. The senior population is analyzed to reach over 16.32% by 2050. This drives the APAC bleeding disorders treatment market with high renal disease, compromised immunity, and a host of other age-related diseases, which disturbs the bleeding and clotting time in the body.

According to the World Federation of Hemophilia, approximately one in 10,000 people are born with this disease. According to the WHO, about 1/3 of new diagnoses occur when there is no family history, majorly affecting the males. According to the Centers for Disease Control, nearly 2% of the population has hemophilia. In addition, according to the CDC, 93% of women with the disease have heavy menstrual bleeding. All these numbers are anticipated to increase in the future and will support the growth of the APAC bleeding disorders treatment market during the prognosis period.

Some of the main factor restraining this market the lack of access to adequate treatment due to the high cost of drugs, unavailability of skilled professionals and the scarcity of availability of specialized health services needed to treat these diseases. Limited healthcare resources will hamper the market growth in some underdeveloped and developing nations in APAC region. In addition, treatment with plasma-derived products may increase the risk of transmission of blood-borne infections like hepatitis and HIV.

This research report on the Asia Pacific Bleeding Disorders Treatment Market has been segmented and sub-segmented into the following categories:

By Drug Class: 

  • Fibrin Sealant
  • Desmopressin
  • Antibrinolytics
  • Recombinant Coagulation Factor Concentrates
  • Plasma Derived Coagulation Factor Concentrates

By Type:

  • vWD
  • Hemophilia A
  • Hemophilia B

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, the Asia Pacific Bleeding Disorders Treatment Market is predicted to rise due to the high expenditure on healthcare facilities, and booming research and development facilities will increase the demand in this region.

The China Bleeding Disorders Treatment Market is analyzed to hold the largest share due to the presence of a large patient pool, the availability of skilled technicians at a comparatively lower cost, and a defined regulatory framework that promotes expedited approval of products.

The India Bleeding Disorders Treatment Market has the highest growth rate, attributed to developing healthcare infrastructure, growing patient awareness, increased public spending, and a large senior population in this region.

Moreover, the rapid increase in India is supporting the market growth and contributing to the overall APAC regional revenues.

KEY MARKET PLAYERS

The Top companies leading in the APAC Bleeding Disorders Treatment Market profiled in the report are CSL Behring, Pfizer Inc., Novo Nordisk, Bayer AG, Biogen Inc., Shire Plc., Medline Plus, Janssen Asia-Pacific Services, LLC, and Grifos SA.,

1.Introduction          

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions                

2. Research Methodology                   

                2.1 Introduction       

                2.2 Research Phases                      

        2.2.1 Secondary Research           

        2.2.2 Primary Research 

        2.2.3 Econometric Modelling      

        2.2.4 Expert Validation  

                2.3 Analysis Design 

                2.4 Study Timeline  

3. Overview               

                3.1 Executive Summary                

                3.2 Key Inferences 

                3.3 Epidemology      

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)            

                4.1 Market Drivers  

                4.2 Market Restraints                    

                4.3 Key Challenges 

                4.4 Current Opportunities in the Market      

5. Market Segmentation                      

                5.1 Drug Class                   

        5.1.1 Introduction           

        5.1.2 Fibrin Sealant         

        5.1.3 Desmopressin       

        5.1.4 Antibrinolytics       

        5.1.5 Recombinant Coagulation Factor Concentrates      

        5.1.6 Plasma Derived Coagulation Factor Concentrates  

        5.1.7  Y-o-Y Growth Analysis, By Drug Class          

        5.1.8  Market Attractiveness Analysis, By Drug Class        

        5.1.9  Market Share Analysis, By Drug Class         

                5.2 Type      

        5.2.1 Introduction           

        5.2.2 vWD           

        5.2.3 Hemophilia A         

        5.2.4 Hemophilia B          

        5.2.5 Y-o-Y Growth Analysis, By Type     

        5.2.6 Market Attractiveness Analysis, By Type   

        5.2.7 Market Share Analysis, By Type     

6. Geographical Analysis                      

                6.1 Introduction       

        6.1.1 Regional Trends    

        6.1.2 Impact Analysis     

        6.1.3 Y-o-Y Growth Analysis        

                        6.1.3.1 By Geographical Area

                        6.1.3.2 By Drug Class

                        6.1.3.3 By Type

        6.1.4  Market Attractiveness Analysis     

                        6.1.4.1 By Geographical Area

                        6.1.4.2 By Drug Class

                        6.1.4.3 By Type

        6.1.5  Market Share Analysis      

                        6.1.5.1 By Geographical Area

                        6.1.5.2 By Drug Class

                        6.1.5.3 By Type

                6.2 China     

                6.3 India      

                6.4 Japan    

                6.5 South Korea       

                6.6 Australia                      

7.Strategic Analysis                

                7.1 PESTLE analysis 

        7.1.1 Political     

        7.1.2 Economic 

        7.1.3 Social         

        7.1.4 Technological         

        7.1.5 Legal          

        7.1.6 Environmental       

                7.2 Porter’s Five analysis      

        7.2.1 Bargaining Power of Suppliers        

        7.2.2 Bargaining Power of Consumers    

        7.2.3 Threat of New Entrants     

        7.2.4 Threat of Substitute Products and Services              

        7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                 

                8.1 CSL Behring                

        8.1.1 Overview 

        8.1.2 Product Analysis   

        8.1.3 Financial analysis  

        8.1.4 Recent Developments       

        8.1.5 SWOT analysis       

        8.1.6 Analyst View          

                8.2 Pfizer Inc.                    

                8.3 Novo Nordisk    

                8.4 Bayer AG                     

                8.5 Biogen Inc.                  

                8.6 Shire Plc.                      

                8.7 LLC                 

                8.8 Medline Plus      

                8.9 Janssen Global Services

                8.10 Grifos SA                   

9.Competitive Landscape                    

                9.1 Market share analysis    

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures 

                9.4 New Product Launches 

10.Market Outlook and Investment Opportunities                  

Appendix                   

                a) List of Tables                

                b) List of Figures      

  1. Asia-Pacific Bleeding Disorders Treatment Market By Drug Class, From 2022 to 2027 ( USD Billion )
  2. Asia-Pacific Fibrin Sealant Market By Region, From 2022 to 2027 ( USD Billion )
  3. Asia-Pacific Desmopressin Market By Region, From 2022 to 2027 ( USD Billion )
  4. Asia-Pacific Antibrinolytics Market By Region, From 2022 to 2027 ( USD Billion )
  5. Asia-Pacific Recombinant Coagulation Factor Concentrates Market By Region, From 2022 to 2027 ( USD Billion )
  6. Asia-Pacific Plasma Derived Coagulation Factor Concentrates Market By Region, From 2022 to 2027 ( USD Billion )
  7. Asia-Pacific Bleeding Disorders Treatment Market By Type, From 2022 to 2027 ( USD Billion )
  8. Asia-Pacific vWD Market By Region, From 2022 to 2027 ( USD Billion )
  9. Asia-Pacific Hemophilia A Market By Region, From 2022 to 2027 ( USD Billion )
  10. Asia-Pacific Hemophilia B Market By Region, From 2022 to 2027 ( USD Billion )
  11. Japan Bleeding Disorders Treatment Market By Drug Class, From 2022 to 2027 ( USD Billion )
  12. Japan Bleeding Disorders Treatment Market By Type, From 2022 to 2027 ( USD Billion )
  13. China Bleeding Disorders Treatment Market By Drug Class, From 2022 to 2027 ( USD Billion )
  14. China Bleeding Disorders Treatment Market By Type, From 2022 to 2027 ( USD Billion )
  15. India Bleeding Disorders Treatment Market By Drug Class, From 2022 to 2027 ( USD Billion )
  16. India Bleeding Disorders Treatment Market By Type, From 2022 to 2027 ( USD Billion )
  17. Australia Bleeding Disorders Treatment Market By Drug Class, From 2022 to 2027 ( USD Billion )
  18. Australia Bleeding Disorders Treatment Market By Type, From 2022 to 2027 ( USD Billion )
  19. South Korea Bleeding Disorders Treatment Market By Drug Class, From 2022 to 2027 ( USD Billion )
  20. South Korea Bleeding Disorders Treatment Market By Type, From 2022 to 2027 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample